| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
O1 Added value of HIV-1 DNA load analysis in routine patient monitoring
|
Mortier, Virginie
|
|
|
2 |
S3 |
p. 1
|
article
|
| 2 |
O8 Cell-associated HIV-1 unspliced RNA level predicts both time to virological suppression and duration of post-treatment virological control in patients treated with temporary early ART
|
Pasternak, Alexander
|
|
|
2 |
S3 |
p. 3
|
article
|
| 3 |
O5 CRISPR/Cas9-derived activation systems as new tools for induction of latent human immunodeficiency virus (HIV)
|
Bialek, JuliaK
|
|
|
2 |
S3 |
p. 2
|
article
|
| 4 |
O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR
|
Rutsaert, S.
|
|
|
2 |
S3 |
p. 1
|
article
|
| 5 |
O7 Implication of DNA methylation in HIV-1 post-integration latency.
|
Verdikt, Roxane
|
|
|
2 |
S3 |
p. 3
|
article
|
| 6 |
O3 Quantifying and characterising the HIV reservoir in virally suppressed patients
|
Pannus, Pieter
|
|
|
2 |
S3 |
p. 1
|
article
|
| 7 |
O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
|
Darcis, Gilles
|
|
|
2 |
S3 |
p. 2
|
article
|
| 8 |
O4 Spatial distribution of HIV in antiretroviral-treated humanised mice
|
Fievez, Virginie
|
|
|
2 |
S3 |
p. 1-2
|
article
|
| 9 |
P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days
|
Robberechts, Martine
|
|
|
2 |
S3 |
p. 4
|
article
|
| 10 |
P3 Early evidence of antiviral activity and safety of ABX464 in HIV treatment-naïve patients
|
Scherrer, Didier
|
|
|
2 |
S3 |
p. 4-5
|
article
|
| 11 |
P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix)
|
Tjok Joe, P.
|
|
|
2 |
S3 |
p. 5
|
article
|
| 12 |
P1 Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro latency models
|
Bonczkowski, Pawel
|
|
|
2 |
S3 |
p. 4
|
article
|
Journal description